A detailed history of Versant Capital Management, Inc transactions in Mannkind Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 730 shares of MNKD stock, worth $4,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
730
Holding current value
$4,730
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$5.93 - $7.44 $4,328 - $5,431
730 New
730 $4,000
Q1 2021

Apr 27, 2021

BUY
$3.14 - $6.14 $31,400 - $61,400
10,000 New
10,000 $39,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.67B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.